Jefferson Davis

Questioner
DISC Type : c

Co-Founder & Board Member at Stealth Biopharmaceutical Company

United States

Overview

Jefferson Davis is a biopharmaceutical entrepreneur, currently Co-Founder and Board Member at a stealth company. With an MBA from Duke University, he previously served as Chief Business Officer at Acer Therapeutics, guiding it through its acquisition by Zevra Therapeutics in 2023.

An alumnus of both Duke University and North Carolina State University, he maintains strong ties to his alma maters. His social feed indicates he actively follows and celebrates the successes of his peers and colleagues within the biopharmaceutical industry, showing a keen interest in collective progress.

He played a key executive role in the successful acquisition of Acer Therapeutics by Zevra Therapeutics.

Personality Overview

Cautious & Analytical

Systematic

Value Seeker

While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.  They prefer to do thorough analysis of any situation. They are more likely than others to negotiate on pricing and terms.

Topics They Care About

Rare Disease Therapeutics
He shows a particular interest in treatments for Phenylketonuria (PKU), frequently congratulating companies on advancements that benefit patients with rare conditions.
Biopharma M&A
His experience as Chief Business Officer during Acer Therapeutics' acquisition by Zevra highlights his expertise in corporate development and strategic transactions.
Industry Collaboration
He consistently celebrates the accomplishments of other teams and companies in his network, showing he values collective industry success.

Media Appearances

Jefferson has no verified media appearances

Work History

12-2023
Co-Founder & Board Member at Stealth Biopharmaceutical Company
8-2016
Professional at Armory Group | Asset Management, Consulting, Investment Banking
2-2021 - 11-2023
Chief Business Officer at Acer Therapeutics Inc.
7-2020 - 2-2021
Head Of Corporate Development at Acer Therapeutics Inc.
10-2014 - 7-2020
Partner at Extera Partners

Education

1993 - 1995
MBA from Duke University
1985 - 1990
B.S. from North Carolina State University

More Information

Social Presence :

Prographics :

Exp : 14 Location : United States Job Level : Leadership Designation : Co-Founder & Board Member at Stealth Biopharmaceutical Company
URL has been copied!

Insights For Selling To Jefferson

During A Call Or A Meeting

DO's

  • If you have a lower priced product compared to the competition, call out the same
  • Keep some extra margin in hand as they will likely negotiate the pricing
  • Emphasize on objective proof of ROI, help them do a thorough evaluation

DONT's

  • Don’t overhype the product/pitch, keep it measured
  • Avoid rushing them, be polite and patient
  • Don’t depend too much on anecdotal evidence, it reduces their confidence

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Jefferson is

  • Confidence that the product provides ROI, effective pricing and process adherence matter the most to them.

  • Will you ever get a clear answer from Jefferson

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Jefferson move?

  • They can move at a reasonable pace while making their decisions if they have the necessary information.

  • Can Jefferson take some risk or not?

  • They can take some risk if they are confident that they have analyzed the circumstances well.


You And Jefferson

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.